Back | Next |
home / stock / nrbo / nrbo message board
Subject | By | Source | When |
---|---|---|---|
$NRBO short data if anyone is interested | SmellMyFinger | investorshub | 01/20/2024 7:35:42 AM |
$NRBO The now | BesaoT35 | investorshub | 01/20/2024 6:47:25 AM |
got some short data | PENNY DIPZ | investorshub | 01/20/2024 4:45:05 AM |
Price now | tw0122 | investorshub | 01/20/2024 4:33:04 AM |
The now | FROZENFLAME | investorshub | 01/20/2024 12:29:00 AM |
$NRBO The now | db101 | investorshub | 01/19/2024 10:18:13 PM |
The trading last up | BesaoT35 | investorshub | 01/19/2024 8:51:35 PM |
$NRBO Price trading last up | reena969 | investorshub | 01/19/2024 7:59:55 PM |
$NRBO just the news we needed | tw0122 | investorshub | 01/19/2024 7:11:04 PM |
The now | BesaoT35 | investorshub | 01/19/2024 6:28:42 PM |
$NRBO bears and bulls | PENNY DIPZ | investorshub | 01/19/2024 6:22:34 PM |
$NRBO oh yeah news for the day | SmellMyFinger | investorshub | 01/19/2024 5:20:48 PM |
$NRBO short data if anyone is interested | reena969 | investorshub | 01/18/2024 7:16:06 PM |
$NRBO MomentumIts now | 81vette | investorshub | 01/18/2024 9:03:41 AM |
The now | Arnold25764 | investorshub | 01/18/2024 5:30:33 AM |
The gaining last up | SmellMyFinger | investorshub | 01/18/2024 5:18:02 AM |
$NRBO got some short data | PENNY DIPZ | investorshub | 01/18/2024 3:47:25 AM |
$NRBO and the shorts continue | BJ-Trader | investorshub | 01/17/2024 10:29:53 PM |
Price now up | tw0122 | investorshub | 01/17/2024 9:25:37 PM |
MomentumIts now | SmellMyFinger | investorshub | 01/17/2024 9:04:35 PM |
News, Short Squeeze, Breakout and More Instantly...
NeuroBo Pharmaceuticals Inc. Company Name:
NRBO Stock Symbol:
NASDAQ Market:
NeuroBo Pharmaceuticals Inc. Website:
NeuroBo Pharmaceuticals Doses First Patient in the MAD Part 2 of Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity PR Newswire Top-Line Data Readout From the Single Ascending Dose Part 1 Expected in the Third Quarter of 2024, and From the Multiple Asce...
NeuroBo Pharmaceuticals Announces the Closing of up to $70 Million Concurrent Private Placement and Registered Direct Offering Priced At-the-Market Under Nasdaq Rules PR Newswire $20 million upfront with up to an additional $50 million of aggregate gross proceeds upon ...
NeuroBo Pharmaceuticals Announces up to $70 Million Concurrent Private Placement and Registered Direct Offering Priced At-the-Market Under Nasdaq Rules PR Newswire $20 million upfront with up to an additional $50 million of aggregate gross proceeds upon the exercise in...